FDA Inspection 661411 — Neopharm Labs Inc.
The FDA completed an inspection of Neopharm Labs Inc. on February 16, 2010 in Blainville. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Blainville (Canada)